Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Sets Fiscal 2019 Cash Dividend Rate, and Provides Fiscal 2019 Guidance
CINCINNATI, Nov. 08, 2018 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fourth quarter and fiscal year ended September 30, 2018. Business Highlights: Completed consolidation of separately-run businesses into two integrated global business units Streamlined organization to build a stronger, more efficient and sustainable management structure Entered into a […]